These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9269603)

  • 1. Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
    Marone P; Bono L; Carretto E; Barbarini D; Telecco S
    J Chemother; 1997 Aug; 9(4):247-50. PubMed ID: 9269603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs.
    Krishnan MY; Manning EJ; Collins MT
    J Antimicrob Chemother; 2009 Aug; 64(2):310-6. PubMed ID: 19457932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
    Mascellino MT; Iona E; Fattorini L; De Gregoris P; Hu CQ; Santoro C; Orefici G
    J Chemother; 1991 Dec; 3(6):357-62. PubMed ID: 1840274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Etest for rapid susceptibility testing of Mycobacterium avium to clarithromycin.
    Lebrun L; Onody C; Vincent V; Nordmann P
    J Antimicrob Chemother; 1996 May; 37(5):999-1003. PubMed ID: 8737150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
    Esteban J; Gadea I; Torres MV; Cabria F; Rollan E; Santos-O'Connor FG; Fernández-Roblas R; Soriano F
    J Chemother; 2002 Dec; 14(6):547-53. PubMed ID: 12583544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new method for rapid drug susceptibility testing of Mycobacterium avium complex isolates by using the mycobacteria growth indicator tube.
    Piersimoni C; Nista D; Bornigia S; De Sio G
    J Clin Microbiol; 1998 Jan; 36(1):64-7. PubMed ID: 9431921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials.
    Miltner EC; Bermudez LE
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1990-4. PubMed ID: 10858369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric testing of susceptibilities of Mycobacterium avium to amikacin, ciprofloxacin, clarithromycin and rifabutin in 24 hours.
    Vena RM; Munson EL; DeCoster DJ; Croke CL; Fett DB; Callister SM; Schell RF
    Clin Microbiol Infect; 2000 Jul; 6(7):368-75. PubMed ID: 11168153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
    Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
    Lin S; Hua W; Wang S; Zhang Y; Chen X; Liu H; Shao L; Chen J; Zhang W
    BMC Microbiol; 2022 Jul; 22(1):175. PubMed ID: 35804298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
    Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
    J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods.
    Inderlied CB; Young LS; Yamada JK
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1697-702. PubMed ID: 3124736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST.
    Hombach M; Somoskövi A; Hömke R; Ritter C; Böttger EC
    Int J Med Microbiol; 2013 Jul; 303(5):270-6. PubMed ID: 23689069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAC management.
    PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
    Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K
    Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of azithromycin and clarithromycin in their interactions with rifabutin in healthy volunteers.
    Apseloff G; Foulds G; LaBoy-Goral L; Willavize S; Vincent J
    J Clin Pharmacol; 1998 Sep; 38(9):830-5. PubMed ID: 9753212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.